.png){kind=icon}
返回
Schistosomiasis control:: keep taking the tablets
.png){kind=icon}
PRE
AI
DOI：10.1016/j.pt.2003.11.010.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Despite the limited reports of praziquantel resistance, the relative success of chemotherapy-based control programmes for schistosomiasis has prompted overdue efforts to expand the use of cheap, generic, praziquantel in sub-Saharan Africa. The likely impact of such programmes on the development and spread of praziquantel resistance is uncertain, but this possibility reinforces the need for monitoring the spectrum of praziquantel sensitivity of schistosome populations and for an improved knowledge, of the precise targets for the action of the drug. The search for alternatives to praziquantel and other tools for control of schistosomiasis must continue.
Keyword:
PRAZIQUANTEL-RESISTANT
MANSONI INFECTIONS
TEGUMENTAL DAMAGE
IN-VITRO
EFFICACY
CHEMOTHERAPY
JAPONICUM
ARTESUNATE
ARTEMETHER
RESPONSES
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.6
论文数:
3.1K
被引数:
8.2K
机构
暂无机构信息
引用论文
CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children
OAAI
.png){kind=icon}
OAAI分享收藏分享收藏分享收藏分享收藏
查看更多内容